Hemolytic anemia
4 papers
- Humans1
- Animals2
Trial sponsors
Novartis Pharmaceuticals Corporation
Company1 trialPhase 2212 people
Institute of Hematology & Blood Diseases Hospital, China
3 trialsPhase 2270 people
Latest
1 in 12 monthsInternational Journal of Endocrinology and Metabolism
Discordantly Low HbA1c in Patients Receiving Dapsone: Prevalence and Associations with Hemolysis and Methemoglobinemia
Cross-sectional study in peopleHbA1c
Immunobiology
A Flow Cytometric Approach to Assess RBC-Bound IgG Antibodies in Different Age Populations
Study in peopleMechanisms
The Journals of Gerontology, Series A
Black Americans With Sickle Cell Disease (SCD) Demonstrate Accelerated Epigenetic Pace of Aging Compared to Black Americans Without SCD
Study in peopleBiomarkers
Journal of Atherosclerosis and Thrombosis
The Elderly with Glucose-6-Phosphate Dehydrogenase Deficiency are More Susceptible to Cardiovascular Disease
Case-control study of 9,604 peopleCardiovascular disease
Journal of Cellular Biochemistry
Neuroprotection by glucose-6-phosphate dehydrogenase and the pentose phosphate pathway
ReviewMechanisms
Experimental Hematology
Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease
Experiments in micemTOR signalling
Free Radical Research
The SOD1 transgene expressed in erythroid cells alleviates fatal phenotype in congenic NZB/NZW-F1 mice
Experiments in miceInterventions
International Journal of Immunopharmacology
Innervation of lymphoid organs and implications in development, aging, and autoimmunity
ReviewMechanisms